Last reviewed · How we verify

Levomethamphetamine (LEVMETAMFETAMINE)

FDA-approved active Small molecule Quality 25/100

At a glance

Generic nameLEVMETAMFETAMINE
Drug classlevmetamfetamine
TargetTrace amine-associated receptor 1
ModalitySmall molecule
Therapeutic areaHematology
PhaseFDA-approved
Annual revenue172

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results
SEC EDGARRevenue + earnings

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: